Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank20
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P20
Within normal range
Average
-91.83%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%-
20220.00%-
20210.00%+100.0%
2020-550.97%-
20190.00%-